Curia is a global CDMO headquartered in New York, providing end-to-end services for both small molecules and biologics. With over 30 years of experience and 29 facilities worldwide, Curia supports clients from discovery through commercial manufacturing with expertise in process and analytical development, formulation, scale-up, and sterile fill/finish. The company also offers integrated mRNA capabilities, including pDNA production, LNP formulation, and enzyme and nucleoside manufacturing, enabling full support for mRNA vaccines and therapeutics from development to commercialization.
